BFC Planning’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$147K Buy
2,872
+195
+7% +$10.3K 0.01% 1060
2026
Q2
$132K Sell
2,677
-1,724
-39% -$87.5K 0.01% 1110
2026
Q1
$235K Sell
4,401
-250
-5% -$14.7K 0.01% 814
2025
Q4
$289K Buy
4,651
+4,196
+922% +$259K 0.01% 732
2025
Q3
$27.3K Hold
455
– – ﹤0.01% 1425
2025
Q2
$28.5K Sell
455
-75
-14% -$4.51K ﹤0.01% 1348
2025
Q1
$31.9K Sell
530
-215
-29% -$13.4K ﹤0.01% 1274
2024
Q4
$43.5K Sell
745
-515
-41% -$30.6K ﹤0.01% 1165
2024
Q3
$74.6K Buy
+1,260
New +$72K 0.01% 976

Other funds holding IHI

BFC Planning's IHI Position: Q3 2026 in Review

BFC Planning increased its iShares US Medical Devices ETF (IHI) stake by 7.3% in Q3 2026, buying an estimated $10.3K and bringing the position to 2,872 shares worth $147K. The position accounts for 0.01% of the portfolio, ranked #1060.

BFC Planning first reported a position in IHI in Q3 2024 and has held it in 9 quarters since. The position peaked at $289K in Q4 2025. 459 funds tracked by Wall St. Rank hold IHI as of Q3 2026.

  • BFC Planning held 2,872 shares of iShares US Medical Devices ETF worth $147K as of Q3 2026.
  • BFC Planning bought 195 iShares US Medical Devices ETF shares in Q3 2026, an estimated $10.3K.
  • iShares US Medical Devices ETF made up 0.01% of BFC Planning's portfolio in Q3 2026, its #1060 holding.
  • BFC Planning first reported a position in iShares US Medical Devices ETF in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's iShares US Medical Devices ETF position peaked at $289K in Q4 2025.
  • 459 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.